BURLINGTON, Mass., July 25, 2016 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) announced today that
it will host a conference call and webcast to report its second-quarter 2016 financial results on Wednesday, August 3, 2016, at
4:30 p.m. ET.
The dial-in number for the conference call is (855) 770-0022 for domestic participants and (908) 982-4677 for
international participants, with Conference ID #55311625. A live webcast of the conference call can also be accessed through the
“Investors” tab on the Flexion Therapeutics website. A webcast replay will be available online
after the call.
About Flexion Therapeutics
Flexion is a specialty pharmaceutical company focused on the development and commercialization of novel, local
therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA). The company's lead
product candidate, Zilretta™, is being investigated for its potential to provide improved analgesic therapy for the millions of
U.S. patients who receive intra-articular (IA) injections for knee OA annually.
Investor Contact David Carey Lazar Partners LTD T: 212-867-1768 dcarey@lazarpartners.com Corporate Contact Fred Driscoll Chief Financial Officer Flexion Therapeutics, Inc. T: 781-305-7763 fdriscoll@flexiontherapeutics.com
